GlassScriptPhysician profile
Moona Haque
NPI 1770582587
$3,627.49
in general payments reported to CMS, 2019-2025
36 companies · $602 in 2025
The $602 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $727 · 2020: $159 · 2021: $336 · 2022: $661 · 2023: $625 · 2024: $518 · 2025: $602.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,746.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,745.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $653.26 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $285.16 | 2019-2025 | |
| Therapeuticsmd, INC. | $265.88 | 2019-2022 | |
| Sage Therapeutics, LLC | $246.64 | 2024-2025 | Zurzuvae |
| Millicent US INC | $228.66 | 2019-2025 | Intrarosa, Femring, Femlyv |
| Mayne Pharma Commercial LLC | $185.96 | 2023-2025 | |
| Astellas Pharma US INC | $178.17 | 2022-2025 | Veozah, Myrbetriq |
| Shield Therapeutics INC | $175.48 | 2022-2025 | Accrufer |
| Hologic Sales and Service, LLC | $164.69 | 2019-2025 | Thinprep 2000 Processor, Aptima, Myosure Tissue Removal Device |
| Pfizer INC. | $127.26 | 2022-2024 | |
| Exact Sciences Corporation | $119.29 | 2023-2024 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $96.51 | 2019-2023 | Gardasil 9 |
| Medtronic, INC. | $87.28 | 2023-2024 | Harmony, Truclear |
| Exeltis, USA INC. | $67.45 | 2019-2024 | Slynd |
| Coopersurgical, INC. | $64.22 | 2022-2025 | Paragard T 380a, Paragard T 380a |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $62.60 | 2022-2025 | Nexplanon |
| Allergan, INC. | $59.67 | 2019-2020 | |
| Allotrope Medical, INC | $57.03 | 2021 | |
| Myovant Sciences INC. | $52.06 | 2022 | |
| Lupin INC. | $51.97 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $49.09 | 2019 | |
| Evofem Biosciences, INC. | $46.73 | 2021-2022 | |
| Smith+Nephew, INC. | $39.58 | 2025 | Pico 7 |
| Mylan Pharmaceuticals INC. | $37.90 | 2022 | |
| Davol INC. | $31.54 | 2024 | Arista Ah Flexitip |
| Covidien LP | $29.80 | 2019 | |
| Meditrina | $29.34 | 2024-2025 | |
| Aspira Women'S Health INC | $19.49 | 2024 | Ova1 |
| Ethicon US, LLC | $19.31 | 2025 | Enseal |
| Bausch Health US, LLC | $18.52 | 2021 | |
| Dexcom, INC. | $16.75 | 2025 | Dexcom G6 Transmitter |
| Optumhealth Care Solutions, LLC | $15.81 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
| Duchesnay USA Incorporated | $15.32 | 2019 | |
| Renovia INC | $13.89 | 2019 | |
| Agile Therapeutics, INC. | $13.80 | 2024 | Twirla |
| Intuitive Surgical, INC. | $1.38 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Moona Haque listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.